We are thrilled to congratulate Swiss Pharmaceutical and ZHG on the successful launch of ASVON – a groundbreaking combination of Vonoprazan and Aspirin. This innovative sequential approach promises not only enhanced gastric comfort but also critical cardiac and vascular protection.
This launch marks a significant achievement in addressing complex health needs, and we celebrate the dedication and expertise of both Swiss Pharmaceutical and ZHG in reaching this milestone.
We look forward to seeing even greater successes in the future and wish them continued growth and impact in the pharmaceutical industry!